Furthermore, ARTN facilitates the EMT, migration, and invasion of GC cells through GFRA3, with the KRAS inhibitor demonstrating a reduction in the effects of the ARTN-GFRA3 axis [45]. Here, KRAS is linked to gastric cancer.